# FDA Inspection 611523 - AstraZeneca Pharmaceuticals, LP - September 10, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/fe79131e-e500-4b4f-a1d0-9e42f88f4096/
Source feed: FDA_Inspections

> FDA Inspection 611523 for AstraZeneca Pharmaceuticals, LP on September 10, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 611523
- Company Name: AstraZeneca Pharmaceuticals, LP
- Inspection Date: 2009-09-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1211584 - 2023-07-19](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/3c06a69b-bae4-4442-8515-ad030865c29e/)
- [FDA Inspection 1022686 - 2017-08-24](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/6504f213-03f2-4da2-9d08-6b2de9882202/)
- [FDA Inspection 1022686 - 2017-08-24](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/978e6f6a-669a-4555-aea9-217eae041dc3/)
- [FDA Inspection 1022686 - 2017-08-24](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2212a7e-f3ac-42a5-ad63-1ca1b64cf950/)
- [FDA Inspection 895233 - 2014-08-27](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/85d228df-13a6-44d7-8489-95ab6bab3f22/)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/ebec0358-60f4-4d3d-88a0-f03f946518ea

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c